Morita Kei-ichi, Naruto Takuya, Tanimoto Kousuke, Yasukawa Chisato, Oikawa Yu, Masuda Kiyoshi, Imoto Issei, Inazawa Johji, Omura Ken, Harada Hiroyuki
Oral and Maxillofacial Surgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Bioresource Research Center, Tokyo Medical and Dental University, Tokyo, Japan.
PLoS One. 2015 Nov 6;10(11):e0140480. doi: 10.1371/journal.pone.0140480. eCollection 2015.
Gorlin syndrome (GS) is an autosomal dominant disorder that predisposes affected individuals to developmental defects and tumorigenesis, and caused mainly by heterozygous germline PTCH1 mutations. Despite exhaustive analysis, PTCH1 mutations are often unidentifiable in some patients; the failure to detect mutations is presumably because of mutations occurred in other causative genes or outside of analyzed regions of PTCH1, or copy number alterations (CNAs). In this study, we subjected a cohort of GS-affected individuals from six unrelated families to next-generation sequencing (NGS) analysis for the combined screening of causative alterations in Hedgehog signaling pathway-related genes. Specific single nucleotide variations (SNVs) of PTCH1 causing inferred amino acid changes were identified in four families (seven affected individuals), whereas CNAs within or around PTCH1 were found in two families in whom possible causative SNVs were not detected. Through a targeted resequencing of all coding exons, as well as simultaneous evaluation of copy number status using the alignment map files obtained via NGS, we found that GS phenotypes could be explained by PTCH1 mutations or deletions in all affected patients. Because it is advisable to evaluate CNAs of candidate causative genes in point mutation-negative cases, NGS methodology appears to be useful for improving molecular diagnosis through the simultaneous detection of both SNVs and CNAs in the targeted genes/regions.
戈林综合征(GS)是一种常染色体显性疾病,使受影响个体易患发育缺陷和肿瘤发生,主要由种系PTCH1基因杂合突变引起。尽管进行了详尽分析,但在一些患者中PTCH1突变往往无法识别;未能检测到突变可能是因为其他致病基因发生了突变,或者发生在PTCH1分析区域之外,又或者是拷贝数改变(CNA)。在本研究中,我们对来自六个无关家庭的一组GS患者进行了下一代测序(NGS)分析,以联合筛查刺猬信号通路相关基因中的致病改变。在四个家庭(七名受影响个体)中鉴定出了导致推断氨基酸变化的PTCH1特异性单核苷酸变异(SNV),而在未检测到可能致病SNV的两个家庭中发现了PTCH1内部或周围的CNA。通过对所有编码外显子进行靶向重测序,并使用通过NGS获得的比对图谱文件同时评估拷贝数状态,我们发现所有受影响患者的GS表型都可以用PTCH1突变或缺失来解释。由于在点突变阴性病例中评估候选致病基因的CNA是可取的,NGS方法似乎有助于通过同时检测靶向基因/区域中的SNV和CNA来改善分子诊断。